dc.contributor.author | Bedir, A. | |
dc.contributor.author | Bilgici, B. | |
dc.contributor.author | Okuyucu, A. | |
dc.contributor.author | Ozmen, Z. C. | |
dc.contributor.author | Suvaci, D. E. | |
dc.contributor.author | Aliyazicioglu, Y. | |
dc.contributor.author | Kahraman, H. | |
dc.date.accessioned | 2020-06-21T15:20:00Z | |
dc.date.available | 2020-06-21T15:20:00Z | |
dc.date.issued | 2007 | |
dc.identifier.issn | 0009-9147 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/19947 | |
dc.description | 59th Annual Meeting of the American-Association-for-Clinical-Chemistry -- JUL 15-19, 2007 -- San Diego, CA | en_US |
dc.description | WOS: 000246843000327 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | Amer Assoc Clin Chem | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Amer Assoc Clinical Chemistry | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Genotoxic effects of antidiabetic agent pioglitazone on PHA-stimulated human lymphocytes | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 53 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | A104 | en_US |
dc.identifier.endpage | A104 | en_US |
dc.relation.journal | Clinical Chemistry | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |